Gregory A. Rippon, MD, MS
Advertisement
Chief medical partner of neurology, ophthalmology, and internal medicine at Genentech
Articles by Gregory A. Rippon, MD, MS
The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Real-World Survey Data Suggest Deutetrabenazine May Improve Quality of Life Measures in Huntington Disease Chorea
2
Earlier Pimavanserin Initiation May Alter Psychosis Symptom Trajectory in Parkinson's Disease, Exploratory Analysis Suggests
3
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
4
Anti-PACAP Antibody Bocunebart Meets Primary Endpoint in Phase 2b Migraine Prevention Trial
5